Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Non-Muscle Invasive Bladder Neoplasms × pirarubicin × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Wilms Tumor 1 Non-Muscle Invasive Bladder Neoplasms 1 Breast Neoplasms 1

Interventions

Gemcitabine 6 Radiotherapy 3 Mitomycin 3 Epirubicin 2 Docetaxel 2 toripalimab 1 pirarubicin 1 hydroxycamptothecinum 1 Maintenance 1 Injections 1 BCG Vaccine 1 Anesthesia, Spinal 1 Anesthesia, General 1 ALT-803 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07424287 2026-02-20

A Study of Intravesical SHR-1501 Combination With BCG Versus Investigator-selected Chemotherapy in Subjects With BCG-unresponsive NMIBC

Suzhou Suncadia Biopharmaceuticals Co., Ltd.

Phase 3 Not yet recruiting

Non-Muscle Invasive Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡